Institutional HoldersBeta

Who holds a company, from every 13F filed for the quarter, one row per filer exactly as filed, against the latest share count the company reported.

Autonomix Medical, Inc.

CIK 0001617867AMIX· quarter ending 2026-06-30
Shares outstanding
971,043
Held by 13F filers
50,882
5.2% of shares outstanding
Holders
6
+6 vs 2026-03-31 · 6 new, 0 exited
Value
$30K
shares +— vs prior quarter

Share classes (cover page of the 10-Q filed 2026-08-13, as of 2026-08-06)

ClassListedShares outstandingHeld by 13F filers% of classHoldersCUSIP
Common stockAMIX · NASDAQ971,04350,8825.2%605330T304

Each class is compared with its own share count; classes are not added together. A class that is not exchange-listed cannot be held by 13F filers.

Securities (CUSIPs held in 13F this quarter)

tick to combine
CountCUSIPClass (as filers write it)HoldersShares heldClass shares% of classValueOptionsMapped via
05330T304COM650,882971,0435.2%$30K—prefixholders →

Totals combine the ticked CUSIPs and update as you tick: common-stock classes by default; preferreds, notes, warrants and depositary shares are listed but not counted. "holders →" shows a single CUSIP on its own. Bonds are held as a principal amount, not shares. Options positions are never counted as holdings. 2 further CUSIPs map to this company (mostly bonds) but no 13F filer held them this quarter.

Top holders (6 of 6 · 05330T304)

change vs 2026-03-31
#FilerShares% of classValueChange
1Mariner, LLC50,1385.16%$26KNEW
2Allied Private Wealth LLC3470.04%$2KNEW
3Tower Research Capital LLC (TRC)3130.03%$2KNEW
4PNC Financial Services Group, Inc.750.01%$467NEW
5Investors Research Corp80.00%$50NEW
6Networth Advisors, LLC10.00%$6NEW

Large holders from 13D/13G (latest per reporting person, last 2 years)

Filed when a holder crosses 5% or changes materially, so often more current than the quarter-end 13F. Percentages are the filer's own, against the share count they used.

Reporting personFormFiledEventShares% of class
BioStar Ventures III, L.L.C.SCHEDULE 13G/A2025-08-142025-06-30175,2164.3%
BioStar Ventures III, L.P.SCHEDULE 13G/A2025-08-142025-06-30175,2164.3%
Cavalry Fund I LPSCHEDULE 13G/A2025-08-142025-06-3000%
C/M Capital Master Fund, LPSCHEDULE 13G/A2025-08-142025-06-3000%
C/M Capital Partners, LPSCHEDULE 13G/A2025-08-142025-06-3000%
Jonathan JuchnoSCHEDULE 13G/A2025-08-142025-06-3000%
Mercer Street Capital Partners, LLCSCHEDULE 13G/A2025-08-142025-06-3000%
Mercer Street Global Opportunity Fund, LLCSCHEDULE 13G/A2025-08-142025-06-3000%
Thomas WalshSCHEDULE 13G/A2025-08-142025-06-3000%
CVI Investments, Inc.SCHEDULE 13G/A2025-02-072024-12-31116,0874.9%
Heights Capital Management, Inc.SCHEDULE 13G/A2025-02-072024-12-31116,0874.9%

Source: SEC Form 13F-HR information tables for the quarter ending 2026-06-30 (filed within 45 days of quarter end; amendments applied; values normalised to dollars), the share count from the company's latest 10-K/10-Q XBRL cover page, and Schedule 13D/13G filings. Each row is a legal 13F filer as filed — related entities (e.g. Vanguard's advisers) are not merged. Retail brokerage accounts are not reported on 13F, so the remainder is mostly retail and insiders.